| 1 |
Yang Y, Ge J, Lu Y, Zhou Y, Sun H, Li H. Long noncoding RNAs expression profile of RIP2 knockdown in chicken HD11 macrophages associated with avian pathogenic E. coli (APEC) infection. Dev Comp Immunol 2023;142:104650. [PMID: 36736641 DOI: 10.1016/j.dci.2023.104650] [Reference Citation Analysis]
|
| 2 |
Cheng Z, Li L, Zhang Y, Ren Y, Gu J, Wang X, Zhao H, Lu H. HBV-infected hepatocellular carcinoma can be robustly classified into three clinically relevant subgroups by a novel analytical protocol. Brief Bioinform 2023;24:bbac601. [PMID: 36736372 DOI: 10.1093/bib/bbac601] [Reference Citation Analysis]
|
| 3 |
Gholizadeh O, Akbarzadeh S, Moein M, Yasamineh S, Hosseini P, Afkhami H, Amini P, Dadashpour M, Tahavvori A, Eslami M, Hossein Taherian M, Poortahmasebi V. The role of non-coding RNAs in the diagnosis of different stages (HCC, CHB, OBI) of hepatitis B infection. Microb Pathog 2023;176:105995. [PMID: 36681203 DOI: 10.1016/j.micpath.2023.105995] [Reference Citation Analysis]
|
| 4 |
Ahmadi SE, Soleymani M, Shahriyary F, Amirzargar MR, Ofoghi M, Fattahi MD, Safa M. Viral vectors and extracellular vesicles: innate delivery systems utilized in CRISPR/Cas-mediated cancer therapy. Cancer Gene Ther 2023;:1-19. [PMID: 36854897 DOI: 10.1038/s41417-023-00597-z] [Reference Citation Analysis]
|
| 5 |
Xie C, Wang S, Zhang H, Zhu Y, Jiang P, Shi S, Si Y, Chen J. Lnc-AIFM2-1 promotes HBV immune escape by acting as a ceRNA for miR-330-3p to regulate CD244 expression. Front Immunol 2023;14:1121795. [PMID: 36845111 DOI: 10.3389/fimmu.2023.1121795] [Reference Citation Analysis]
|
| 6 |
Bhattacharya A. Epigenetic modifications and regulations in gastrointestinal diseases. Epigenetics in Organ Specific Disorders 2023. [DOI: 10.1016/b978-0-12-823931-5.00005-0] [Reference Citation Analysis]
|
| 7 |
Wang C, Zhou H, Wu R, Guo Y, Gong L, Fu K, Ma C, Peng C, Li Y. Mesenchymal stem cell-derived exosomes and non-coding RNAs: Regulatory and therapeutic role in liver diseases. Biomed Pharmacother 2023;157:114040. [PMID: 36423545 DOI: 10.1016/j.biopha.2022.114040] [Reference Citation Analysis]
|
| 8 |
Hosseini SA, Salehifard Jouneghani A, Ghatrehsamani M, Yaghoobi H, Elahian F, Mirzaei SA. CRISPR/Cas9 as precision and high-throughput genetic engineering tools in gastrointestinal cancer research and therapy. Int J Biol Macromol 2022;223:732-54. [PMID: 36372102 DOI: 10.1016/j.ijbiomac.2022.11.018] [Reference Citation Analysis]
|
| 9 |
Ji M, Deng Z, Rong X, Li R, You Z, Guo X, Cai C, Zhao Y, Gao P, Cao G, Li B, Yang Y. Naringenin Prevents Oxidative Stress and Inflammation in LPS-Induced Liver Injury through the Regulation of LncRNA-mRNA in Male Mice. Molecules 2022;28. [PMID: 36615393 DOI: 10.3390/molecules28010198] [Reference Citation Analysis]
|
| 10 |
Liu J, Zhang H, Xia P, Zhu Y, Xu K, Liu Z, Yuan Y. Genome stability‑related lncRNA ZFPM2‑AS1 promotes tumor progression via miR‑3065‑5p/XRCC4 in hepatocellular carcinoma. Int J Oncol 2023;62:19. [PMID: 36524359 DOI: 10.3892/ijo.2022.5467] [Reference Citation Analysis]
|
| 11 |
He J, Yang L, Huang W, Xu Y, Cui Z, Liang J, Sun J, Huang X, Huang Y, Chen X, Qin Q, Sun H. Identification and characterization of lncRNAs and the interaction of lncRNA-mRNA in Epinephelus coioides induced with Singapore grouper iridovirus infection. Fish & Shellfish Immunology 2022;131:441-453. [DOI: 10.1016/j.fsi.2022.09.069] [Reference Citation Analysis]
|
| 12 |
Cheng Z, Han J, Jiang F, Chen W, Ma X. Prognostic pyroptosis-related lncRNA signature predicts the efficacy of immunotherapy in hepatocellular carcinoma. Biochemistry and Biophysics Reports 2022;32:101389. [DOI: 10.1016/j.bbrep.2022.101389] [Reference Citation Analysis]
|
| 13 |
Hong Y, Zhang Y, Zhao H, Chen H, Yu Q, Cui H. The roles of lncRNA functions and regulatory mechanisms in the diagnosis and treatment of hepatocellular carcinoma. Front Cell Dev Biol 2022;10. [DOI: 10.3389/fcell.2022.1051306] [Reference Citation Analysis]
|
| 14 |
Liu J, Zhang H, Xia P, Zhu Y, Xu K, Liu Z, Yuan Y. The Genome Stability-Related lncRNA ZFPM2-AS1 Promotes Tumor Progression via miR-3065-5p/XRCC4 in Hepatocellular Carcinoma.. [DOI: 10.21203/rs.3.rs-2214269/v1] [Reference Citation Analysis]
|
| 15 |
Pelisek J, Reutersberg B, Greber UF, Zimmermann A. Vascular dysfunction in COVID-19 patients: update on SARS-CoV-2 infection of endothelial cells and the role of long non-coding RNAs. Clinical Science 2022;136:1571-1590. [DOI: 10.1042/cs20220235] [Reference Citation Analysis]
|
| 16 |
Peng JY, Cai DK, Zeng RL, Zhang CY, Li GC, Chen SF, Yuan XQ, Peng L. Upregulation of Superenhancer-Driven LncRNA FASRL by USF1 Promotes De Novo Fatty Acid Biosynthesis to Exacerbate Hepatocellular Carcinoma. Adv Sci (Weinh) 2022;10:e2204711. [PMID: 36307901 DOI: 10.1002/advs.202204711] [Reference Citation Analysis]
|
| 17 |
Mo M, Ma X, Luo Y, Tan C, Liu B, Tang P, Liao Q, Liu S, Yu H, Huang D, Zeng X, Qiu X. Liver-specific lncRNA FAM99A may be a tumor suppressor and promising prognostic biomarker in hepatocellular carcinoma. BMC Cancer 2022;22:1098. [PMID: 36289466 DOI: 10.1186/s12885-022-10186-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 18 |
Ciszewski WM, Sobierajska K, Stasiak A, Wagner W. Lactate drives cellular DNA repair capacity: Role of lactate and related short-chain fatty acids in cervical cancer chemoresistance and viral infection. Front Cell Dev Biol 2022;10:1012254. [DOI: 10.3389/fcell.2022.1012254] [Reference Citation Analysis]
|
| 19 |
Gao S, Jiang X, Wang L, Jiang S, Luo H, Chen Y, Peng C. The pathogenesis of liver cancer and the therapeutic potential of bioactive substances. Front Pharmacol 2022;13:1029601. [DOI: 10.3389/fphar.2022.1029601] [Reference Citation Analysis]
|
| 20 |
Zhang L, Zhang Y, Bao J, Gao W, Wang D, Pan H. Cuproptosis Combined with lncRNAs Predicts the Prognosis and Immune Microenvironment of Breast Cancer. Comput Math Methods Med 2022;2022:5422698. [PMID: 36213577 DOI: 10.1155/2022/5422698] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 21 |
Yan L, Liu A, Jiang L, Wang B. Non-coding RNA and hepatitis B virus-related hepatocellular carcinoma: A bibliometric analysis and systematic review. Front Med 2022;9. [DOI: 10.3389/fmed.2022.995943] [Reference Citation Analysis]
|
| 22 |
Cao M, Yuan D, Jiang H, Zhou G, Chen C, Han G. Long non-coding RNA WAC antisense RNA 1 mediates hepatitis B virus replication <em>in vitro</em> by reinforcing miR-192-5p/ATG7-induced autophagy. Eur J Histochem 2022;66. [PMID: 36053263 DOI: 10.4081/ejh.2022.3438] [Reference Citation Analysis]
|
| 23 |
Lei B, Song H, Xu F, Wei Q, Wang F, Tan G, Ma H. When does hepatitis B virus meet long-stranded noncoding RNAs? Front Microbiol 2022;13:962186. [DOI: 10.3389/fmicb.2022.962186] [Reference Citation Analysis]
|
| 24 |
Xu Y, Liu R. Analysis of the role of m6A and lncRNAs in prognosis and immunotherapy of hepatocellular carcinoma. Heliyon 2022;8:e10612. [PMID: 36158075 DOI: 10.1016/j.heliyon.2022.e10612] [Reference Citation Analysis]
|
| 25 |
Zhao SS, Tao DL, Chen JM, Wu JP, Yang X, Song JK, Zhu XQ, Zhao GH. RNA sequencing reveals dynamic expression of lncRNAs and mRNAs in caprine endometrial epithelial cells induced by Neospora caninum infection. Parasit Vectors 2022;15:297. [PMID: 35999576 DOI: 10.1186/s13071-022-05405-5] [Reference Citation Analysis]
|
| 26 |
Wang J, Zhou Y, Gu C, Ming F, Zhang Y, Yang D. LncRNA SAMD12-AS1 Suppresses Proliferation and Migration of Hepatocellular Carcinoma via p53 Signaling Pathway. Journal of Oncology 2022;2022:1-9. [DOI: 10.1155/2022/9096365] [Reference Citation Analysis]
|
| 27 |
Liu P, Zhang X, Fu Q, Liu C, Luo Q, Yu P, Chen S, Zhang H, Qin T, Zhang Y. LINC01419 Promotes the Proliferation of Hepatoma Cells by Recruiting XRCC5 and Regulating Its Phosphorylation to Repair DNA Damage. Disease Markers 2022;2022:1-10. [DOI: 10.1155/2022/9313680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 28 |
Li HC, Yang CH, Lo SY. Long noncoding RNAs in hepatitis B virus replication and oncogenesis. World J Gastroenterol 2022; 28(25): 2823-2842 [DOI: 10.3748/wjg.v28.i25.2823] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 29 |
Yuan S, Yu H, Yang Z, Qin Y, Ren J, Cheng S, Ren F, Law BYK, Wong VKW, Ng JPL, Zhou Y, He X, Tan M, Zhang Z, Chen J. Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity. Front Pharmacol 2022;13:837115. [DOI: 10.3389/fphar.2022.837115] [Reference Citation Analysis]
|
| 30 |
Guo F, Yuan Y, Chen Z, Gao F, Li X, Wang H, Wang X, Bai G. Downregulation of the long non-coding RNA MALAT1 in tenofovir-treated pregnant women with hepatitis B virus infection promotes immune recovery of natural killer cells via the has-miR-155-5p/HIF-1α axis. International Immunopharmacology 2022;107:108701. [DOI: 10.1016/j.intimp.2022.108701] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 31 |
Zhao LN, Yuan HF, Wang YF, Yun HL, Zheng W, Yuan Y, Geng Y, Zhao M, Feng LY, Zhang XD. IFN-α inhibits HBV transcription and replication by promoting HDAC3-mediated de-2-hydroxyisobutyrylation of histone H4K8 on HBV cccDNA minichromosome in liver. Acta Pharmacol Sin 2022;43:1484-94. [PMID: 34497374 DOI: 10.1038/s41401-021-00765-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 32 |
Bianca C, Sidhartha E, Tiribelli C, El-Khobar KE, Sukowati CHC. Role of hepatitis B virus in development of hepatocellular carcinoma: Focus on covalently closed circular DNA. World J Hepatol 2022;14:866-84. [PMID: 35721287 DOI: 10.4254/wjh.v14.i5.866] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 33 |
Sun Y, Teng Y, Wang L, Zhang Z, Chen C, Wang Y, Zhang X, Xiang P, Song X, Lu J, Li N, Gao L, Liang X, Xia Y, Wu Z, Ma C. LINC01431 Promotes Histone H4R3 Methylation to Impede HBV Covalently Closed Circular DNA Transcription by Stabilizing PRMT1. Adv Sci (Weinh) 2022;9:e2103135. [PMID: 35398991 DOI: 10.1002/advs.202103135] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 34 |
Cheng Y, Shi W, Cui X, Sun L, Nan Y, Yao H, Fan J, Zhu L, Yu L, Zeng X. Long Noncoding RNA TFAP2A-AS1 Suppressed Hepatitis B Virus Replication by Modulating miR-933/HDAC11. Disease Markers 2022;2022:1-11. [DOI: 10.1155/2022/7733390] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 35 |
Li YR, Zong RQ, Zhang HY, Meng XY, Wu FX. Mechanism Analysis of LINC00665 and Its Peptides CIP2A-BP in Hepatocellular Carcinoma. Front Genet 2022;13:861096. [PMID: 35350239 DOI: 10.3389/fgene.2022.861096] [Reference Citation Analysis]
|
| 36 |
Samudh N, Shrilall C, Arbuthnot P, Bloom K, Ely A. Diversity of Dysregulated Long Non-Coding RNAs in HBV-Related Hepatocellular Carcinoma. Front Immunol 2022;13:834650. [PMID: 35154157 DOI: 10.3389/fimmu.2022.834650] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 37 |
Wang X, Yi H, Tu J, Fan W, Wu J, Wang L, Li X, Yan J, Huang H, Huang R. Comprehensive Analysis Identified ASF1B as an Independent Prognostic Factor for HBV-Infected Hepatocellular Carcinoma. Front Oncol 2022;12:838845. [PMID: 35280822 DOI: 10.3389/fonc.2022.838845] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 38 |
Zhang T, Gu HW, Gao JX, Li YS, Tang HB. Ethanol supernatant extracts of Gynura procumbens could treat nanodiethylnitrosamine-induced mouse liver cancer by interfering with inflammatory factors for the tumor microenvironment. J Ethnopharmacol 2022;285:114917. [PMID: 34919988 DOI: 10.1016/j.jep.2021.114917] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 39 |
Chen Y, Zhang J, Liu J, Wang J, Shi C, Lu L, Cheng X, Niu G, Zhang S, Cui D. The Expression and Clinical Significance of PCNAP1 in Hepatocellular Carcinoma Patients. Journal of Immunology Research 2022;2022:1-7. [DOI: 10.1155/2022/1817694] [Reference Citation Analysis]
|
| 40 |
Wang X, Zhou Y, Dong K, Zhang H, Gong J, Wang S. Exosomal lncRNA HMMR-AS1 mediates macrophage polarization through miR-147a/ARID3A axis under hypoxia and affects the progression of hepatocellular carcinoma. Environ Toxicol 2022. [PMID: 35179300 DOI: 10.1002/tox.23489] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 41 |
Song W, Zhang X, Feng L, Lai Y, Li T, Zhang P. Downregulated lncRNA SNHG18 Suppresses the Progression of Hepatitis B Virus-Associated Hepatocellular Carcinoma and Meditates the Antitumor Effect of Oleanolic Acid. CMAR 2022;Volume 14:687-95. [DOI: 10.2147/cmar.s346920] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 42 |
Nassan MA, Aldhahrani A, Amer HH, Elhenawy A, Swelum AA, Ali OM, Zaki YH. Investigation of the Anticancer Effect of α-Aminophosphonates and Arylidine Derivatives of 3-Acetyl-1-aminoquinolin-2(1H)-one on the DMBA Model of Breast Cancer in Albino Rats with In Silico Prediction of Their Thymidylate Synthase Inhibitory Effect. Molecules 2022;27:756. [PMID: 35164019 DOI: 10.3390/molecules27030756] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 43 |
Yuan X, Dong Z, Shen S. LncRNA GACAT3: A Promising Biomarker and Therapeutic Target in Human Cancers. Front Cell Dev Biol 2022;10:785030. [DOI: 10.3389/fcell.2022.785030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 44 |
Singh KP, Gupta S. 3D Modeling of Non-coding RNA Interactions. Advances in Experimental Medicine and Biology 2022. [DOI: 10.1007/978-3-031-08356-3_11] [Reference Citation Analysis]
|
| 45 |
Dang W, Cao P, Yan Q, Yang L, Wang Y, Yang J, Xin S, Zhang J, Li J, Long S, Zhang W, Zhang S, Lu J. IGFBP7-AS1 is a p53-responsive long noncoding RNA downregulated by Epstein-Barr virus that contributes to viral tumorigenesis. Cancer Lett 2021;523:135-47. [PMID: 34634383 DOI: 10.1016/j.canlet.2021.10.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 46 |
Zhao S, Heng N, Weldegebriall Sahlu B, Wang H, Zhu H. Long Noncoding RNAs: Recent Insights into Their Role in Male Infertility and Their Potential as Biomarkers and Therapeutic Targets. Int J Mol Sci 2021;22:13579. [PMID: 34948376 DOI: 10.3390/ijms222413579] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 47 |
Liu S, Qiu J, He W, Geng C, He G, Liu C, Cai D, Liu X, Tian B, Pan H. TUG1 long non-coding RNA enlists the USF1 transcription factor to overexpress ROMO1 leading to hepatocellular carcinoma growth and metastasis. MedComm (2020) 2020;1:386-99. [PMID: 34766130 DOI: 10.1002/mco2.38] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 48 |
Liu QM, He YY, Liu LL, Wang LK. Exosomal lncRNA HOTTIP Mediates Antiviral Effect of Tenofovir Alafenamide (TAF) on HBV Infection. J Inflamm Res 2021;14:5489-500. [PMID: 34720597 DOI: 10.2147/JIR.S315716] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 49 |
Cui D, Li W, Jiang D, Wu J, Xie J, Wu Y. Advances in Multi-Omics Applications in HBV-Associated Hepatocellular Carcinoma. Front Med (Lausanne) 2021;8:754709. [PMID: 34660653 DOI: 10.3389/fmed.2021.754709] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 50 |
Xu Y, Han C, Sun J, Zhao J, Liu Q, An P. Long Noncoding RNA NR2F1-AS1 Enhances the Migration and Invasion of Hepatocellular Carcinoma via Modulating miR-642a/DEK Pathway. J Oncol 2021;2021:6868514. [PMID: 34594378 DOI: 10.1155/2021/6868514] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 51 |
Zhang H, Qin C, An C, Zheng X, Wen S, Chen W, Liu X, Lv Z, Yang P, Xu W, Gao W, Wu Y. Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer. Mol Cancer 2021;20:126. [PMID: 34598686 DOI: 10.1186/s12943-021-01431-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 52 |
Tian Q, Yan X, Yang L, Liu Z, Yuan Z, Zhang Y. lncRNA CYTOR promotes cell proliferation and tumor growth via miR-125b/SEMA4C axis in hepatocellular carcinoma. Oncol Lett 2021;22:796. [PMID: 34584571 DOI: 10.3892/ol.2021.13057] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 53 |
Tsuge M. Are Humanized Mouse Models Useful for Basic Research of Hepatocarcinogenesis through Chronic Hepatitis B Virus Infection? Viruses 2021;13:1920. [PMID: 34696350 DOI: 10.3390/v13101920] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 54 |
Peng XF, Huang SF, Chen LJ, Xu L, Ye WC. Targeting epigenetics and lncRNAs in liver disease: From mechanisms to therapeutics. Pharmacol Res 2021;172:105846. [PMID: 34438063 DOI: 10.1016/j.phrs.2021.105846] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 55 |
Singh P, Kairuz D, Arbuthnot P, Bloom K. Silencing hepatitis B virus covalently closed circular DNA: The potential of an epigenetic therapy approach. World J Gastroenterol 2021; 27(23): 3182-3207 [PMID: 34163105 DOI: 10.3748/wjg.v27.i23.3182] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 56 |
Hao Q, Wang Z, Wang Q, Chen B, Qian H, Liu X, Cao H, Xia W, Jiang J, Lu Z. Identification and characterization of lncRNA AP000253 in occult hepatitis B virus infection. Virol J 2021;18:125. [PMID: 34112188 DOI: 10.1186/s12985-021-01596-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 57 |
Zhang GZ, Wu ZL, Li CY, Ren EH, Yuan WH, Deng YJ, Xie QQ. Development of a Machine Learning-Based Autophagy-Related lncRNA Signature to Improve Prognosis Prediction in Osteosarcoma Patients. Front Mol Biosci 2021;8:615084. [PMID: 34095215 DOI: 10.3389/fmolb.2021.615084] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 58 |
Fu X, Cheng D, Ouyang Y, Li Y, Li R, Peng S, Fu L. Integrated Analysis of Long Noncoding RNA Expression Profiles in Acute-on-Chronic Liver Failure. Biomed Res Int 2021;2021:5387856. [PMID: 34104647 DOI: 10.1155/2021/5387856] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 59 |
de Almeida NAA, Ribeiro CRA, Raposo JV, de Paula VS. Immunotherapy and Gene Therapy for Oncoviruses Infections: A Review. Viruses 2021;13:822. [PMID: 34063186 DOI: 10.3390/v13050822] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 60 |
He M, Hu L, Bai P, Guo T, Liu N, Feng F, Zhang J. LncRNA PCNAP1 Promotes Hepatoma Cell Proliferation through Targeting miR-340-5p and is Associated with Patient Survival. J Oncol 2021;2021:6627173. [PMID: 34007276 DOI: 10.1155/2021/6627173] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 61 |
Lim LJ, Ling LH, Neo YP, Chung AYF, Goh BKP, Chow PKH, Chan CY, Cheow PC, Lee SY, Lim TKH, Chong SS, Ooi LLPJ, Lee CG. Highly deregulated lncRNA LOC is associated with overall worse prognosis in Hepatocellular Carcinoma patients. J Cancer 2021;12:3098-113. [PMID: 33976720 DOI: 10.7150/jca.56340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 62 |
Ren F, Ren JH, Song CL, Tan M, Yu HB, Zhou YJ, Qin YP, Cheng ST, Zhang Y, Huang AL, Chen J, Yang X. LncRNA HOTAIR modulates hepatitis B virus transcription and replication by enhancing SP1 transcription factor. Clin Sci (Lond) 2020;134:3007-22. [PMID: 33103728 DOI: 10.1042/CS20200970] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 63 |
Wu J, Zhang T, Chen Y, Ha S. MiR-139-5p influences hepatocellular carcinoma cell invasion and proliferation capacities via decreasing SLITRK4 expression. Biosci Rep 2020;40:BSR20193295. [PMID: 32285917 DOI: 10.1042/BSR20193295] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 64 |
Zhu H, Zhang H, Pei Y, Liao Z, Liu F, Su C, Liu Y, Dong R, Song J, Zhang X, Fan Y, Liang H, Zhang B, Chen X. Long non-coding RNA CCDC183-AS1 acts AS a miR-589-5p sponge to promote the progression of hepatocellular carcinoma through regulating SKP1 expression.J Exp Clin Cancer Res. 2021;40:57. [PMID: 33541391 DOI: 10.1186/s13046-021-01861-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 65 |
Yu L, Qiao R, Xu J, Han B, Zhong R. FAM207BP, a pseudogene-derived lncRNA, facilitates proliferation, migration and invasion of lung adenocarcinoma cells and acts as an immune-related prognostic factor. Life Sci 2021;268:119022. [PMID: 33434533 DOI: 10.1016/j.lfs.2021.119022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 66 |
Bai Y, Deng S. A six-long noncoding RNA model predicts prognosis in lung adenocarcinoma. Transl Cancer Res 2020;9:7505-18. [PMID: 35117351 DOI: 10.21037/tcr-20-2436] [Reference Citation Analysis]
|
| 67 |
Chen L, Li Z, Zeng T, Zhang YH, Liu D, Li H, Huang T, Cai YD. Identifying Robust Microbiota Signatures and Interpretable Rules to Distinguish Cancer Subtypes. Front Mol Biosci 2020;7:604794. [PMID: 33330634 DOI: 10.3389/fmolb.2020.604794] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 68 |
Xie C, Li SY, Fang JH, Zhu Y, Yang JE. Functional long non-coding RNAs in hepatocellular carcinoma. Cancer Lett 2021;500:281-91. [PMID: 33129957 DOI: 10.1016/j.canlet.2020.10.042] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 69 |
Hao F, Fei X, Ren X, Xi Xiao J, Chen Y, Wang J. Pseudogene AKR1B10P1 enhances tumorigenicity and regulates epithelial-mesenchymal transition in hepatocellular carcinoma via stabilizing SOX4. J Cell Mol Med 2020;24:11779-90. [PMID: 32924268 DOI: 10.1111/jcmm.15790] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 70 |
Cao P, Jin Q, Feng L, Li H, Qin G, Zhou G. Emerging roles and potential clinical applications of noncoding RNAs in hepatocellular carcinoma. Semin Cancer Biol 2020:S1044-579X(20)30191-7. [PMID: 32931952 DOI: 10.1016/j.semcancer.2020.09.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 71 |
Li L, Song X, Lv Y, Jiang Q, Fan C, Huang D. Landscape of associations between long non-coding RNAs and infiltrating immune cells in liver hepatocellular carcinoma. J Cell Mol Med 2020;24:11243-53. [PMID: 32910548 DOI: 10.1111/jcmm.15690] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 72 |
Yuan Y, Yuan H, Yang G, Yun H, Zhao M, Liu Z, Zhao L, Geng Y, Liu L, Wang J, Zhang H, Wang Y, Zhang XD. IFN-α confers epigenetic regulation of HBV cccDNA minichromosome by modulating GCN5-mediated succinylation of histone H3K79 to clear HBV cccDNA. Clin Epigenetics 2020;12:135. [PMID: 32894195 DOI: 10.1186/s13148-020-00928-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 73 |
Wang Z, Wang W, Wang L. Epigenetic regulation of covalently closed circular DNA minichromosome in hepatitis B virus infection. Biophys Rep 2020;6:115-26. [DOI: 10.1007/s41048-020-00112-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 74 |
Lou W, Ding B, Zhong G, Yao J, Fan W, Fu P. RP11-480I12.5-004 Promotes Growth and Tumorigenesis of Breast Cancer by Relieving miR-29c-3p-Mediated AKT3 and CDK6 Degradation. Mol Ther Nucleic Acids 2020;21:916-31. [PMID: 32810693 DOI: 10.1016/j.omtn.2020.07.022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 75 |
Liu Z, Wang J, Liu L, Yuan H, Bu Y, Feng J, Liu Y, Yang G, Zhao M, Yuan Y, Zhang H, Yun H, Zhang X. Chronic ethanol consumption and HBV induce abnormal lipid metabolism through HBx/SWELL1/arachidonic acid signaling and activate Tregs in HBV-Tg mice. Theranostics 2020;10:9249-67. [PMID: 32802190 DOI: 10.7150/thno.46005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 76 |
Wang Y, Wang Y, Luo W, Song X, Huang L, Xiao J, Jin F, Ren Z, Wang Y. Roles of long non-coding RNAs and emerging RNA-binding proteins in innate antiviral responses. Theranostics 2020;10:9407-24. [PMID: 32802200 DOI: 10.7150/thno.48520] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 77 |
Yu Y, He Y, Shao Y, Chen Q, Liu H. lncRNA PCNAP1 predicts poor prognosis in breast cancer and promotes cancer metastasis via miR‑340‑5p‑dependent upregulation of SOX4. Oncol Rep 2020;44:1511-23. [PMID: 32945462 DOI: 10.3892/or.2020.7699] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 78 |
Ligat G, Goto K, Verrier E, Baumert TF. Targeting Viral cccDNA for Cure of Chronic Hepatitis B. Curr Hepatology Rep 2020;19:235-44. [DOI: 10.1007/s11901-020-00534-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 79 |
Nazarizadeh A, Mohammadi F, Alian F, Faraji P, Nourbakhsh M, Alizadeh-Fanalou S. MicroRNA-154: A Novel Candidate for Diagnosis and Therapy of Human Cancers. Onco Targets Ther 2020;13:6603-15. [PMID: 32753896 DOI: 10.2147/OTT.S249268] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 80 |
Li Y, Li G, Chen X, Huang H, Liao L, Yuan T, Deng S. A Novel lncRNA NONHSAT053785 Acts as an Independent Risk Factor for Intrahepatic Metastasis of Hepatocellular Carcinoma. Onco Targets Ther 2020;13:5455-66. [PMID: 32606762 DOI: 10.2147/OTT.S254455] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 81 |
Lin Y, Chen Z, Hu C, Chen Z, Zhang L. Recent progress in antitumor functions of the intracellular antibodies. Drug Discovery Today 2020;25:1109-20. [DOI: 10.1016/j.drudis.2020.02.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 82 |
Zhang S, Qiu D, Xie X, Shen Y. Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis. BMC Cancer 2020;20:343. [PMID: 32321469 DOI: 10.1186/s12885-020-06850-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 83 |
Santos RM, Moreno C, Zhang WC. Non-Coding RNAs in Lung Tumor Initiation and Progression. Int J Mol Sci 2020;21:E2774. [PMID: 32316322 DOI: 10.3390/ijms21082774] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 84 |
Zhang S, Zhou Y, Wang Y, Wang Z, Xiao Q, Zhang Y, Lou Y, Qiu Y, Zhu F. The mechanistic, diagnostic and therapeutic novel nucleic acids for hepatocellular carcinoma emerging in past score years. Brief Bioinform 2021;22:1860-83. [PMID: 32249290 DOI: 10.1093/bib/bbaa023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 85 |
Lou W, Ding B, Fu P. Pseudogene-Derived lncRNAs and Their miRNA Sponging Mechanism in Human Cancer. Front Cell Dev Biol 2020;8:85. [PMID: 32185172 DOI: 10.3389/fcell.2020.00085] [Cited by in Crossref: 69] [Cited by in F6Publishing: 77] [Article Influence: 23.0] [Reference Citation Analysis]
|
| 86 |
Liu W, Yang YJ, An Q. LINC00963 Promotes Ovarian Cancer Proliferation, Migration and EMT via the miR-378g /CHI3L1 Axis. Cancer Manag Res 2020;12:463-73. [PMID: 32021459 DOI: 10.2147/CMAR.S229083] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 87 |
Dou X, Feng L, Ying N, Ding Q, Song Q, Jiang F, Wang C, Li S. RNA Sequencing Reveals a Comprehensive Circular RNA Expression Profile in a Mouse Model of Alcoholic Liver Disease. Alcohol Clin Exp Res 2020;44:415-22. [DOI: 10.1111/acer.14265] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 88 |
Chen X, Wan L, Wang W, Xi WJ, Yang AG, Wang T. Re-recognition of pseudogenes: From molecular to clinical applications. Theranostics 2020;10:1479-99. [PMID: 32042317 DOI: 10.7150/thno.40659] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 89 |
Sun J, Zhang Y, Li B, Dong Y, Sun C, Zhang F, Jin L, Chen D, Wang W. PITPNA-AS1 abrogates the inhibition of miR-876-5p on WNT5A to facilitate hepatocellular carcinoma progression. Cell Death Dis 2019;10:844. [PMID: 31700026 DOI: 10.1038/s41419-019-2067-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 90 |
Yang G, Feng J, Liu Y, Zhao M, Yuan Y, Yuan H, Yun H, Sun M, Bu Y, Liu L, Liu Z, Niu JQ, Yin M, Song X, Miao Z, Lin Z, Zhang X. HAT1 signaling confers to assembly and epigenetic regulation of HBV cccDNA minichromosome. Theranostics 2019;9:7345-58. [PMID: 31695772 DOI: 10.7150/thno.37173] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
|
